These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12654622)

  • 1. Pretreatment of patients with atrial fibrillation who undergo electrical cardioversion.
    Stabile G; Turco P; De Simone A
    Circulation; 2003 Mar; 107(11):e75; author reply e75. PubMed ID: 12654622
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.
    Madrid AH; Bueno MG; Rebollo JM; Marín I; Peña G; Bernal E; Rodriguez A; Cano L; Cano JM; Cabeza P; Moro C
    Circulation; 2002 Jul; 106(3):331-6. PubMed ID: 12119249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial.
    Madrid AH; Escobar C; Rebollo JM; Marín I; Bernal E; Nannini S; Limón L; Peng J; Moro C
    Card Electrophysiol Rev; 2003 Sep; 7(3):243-6. PubMed ID: 14739722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers.
    Madrid AH; Marín IM; Cervantes CE; Morell EB; Estévez JE; Moreno G; Parajón JR; Peng J; Limón L; Nannini S; Moro C
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):114-20. PubMed ID: 15526246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of amiodarone plus irbesartan regimen versus amiodarone alone on maintaining sinus rhythm in rheumatic heart disease patients with persistent atrial fibrillation post valve replacement and cardioversion].
    Ding P; Li L; Zhang H; Chen LJ; Deng XJ; Yuan YQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):505-8. PubMed ID: 19927630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate control at least as effective as rhythm control for AF patients.
    Geriatrics; 2002 May; 57(5):63. PubMed ID: 12040594
    [No Abstract]   [Full Text] [Related]  

  • 7. Amiodarone before electrical cardioversion of atrial fibrillation.
    Veloso HH
    Am J Cardiol; 2001 Aug; 88(4):466. PubMed ID: 11558468
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sartan improves anti-arrhythmia therapy after cardioversion. Fewer recurrent fibrillation incidents].
    MMW Fortschr Med; 2002 Sep; 144(37):56. PubMed ID: 12380344
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs to promote sinus rhythm reversion and maintenance in atrial fibrillation--why amiodarone is better.
    Nattel S
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):5-6. PubMed ID: 12916518
    [No Abstract]   [Full Text] [Related]  

  • 10. Findings suggest revised atrial fibrillation approach.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(1):7-9. PubMed ID: 12762304
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical efficacy of irbesartan and amiodarone in elderly patients with paroxysmal atrial fibrillation].
    Cao DJ; Mu CY; Tong F; Tang RB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):871-4. PubMed ID: 18812670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation.
    Samuels LE; Holmes EC; Samuels FL
    Ann Thorac Surg; 2005 Jan; 79(1):113-6. PubMed ID: 15620926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone.
    Van Noord T; Van Gelder IC; Schoonderwoerd BA; Crijns HJ
    Am J Cardiol; 2000 Dec; 86(12):1384-5, A5. PubMed ID: 11113420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
    Yamabe H; Kaikita K; Matsumura T; Iwasa A; Koyama J; Uemura T; Morikami Y; Tsunoda R; Morihisa K; Fujimoto K; Kajiwara I; Matsui K; Tsujita K; Ogawa H
    J Cardiol; 2018 Feb; 71(2):129-134. PubMed ID: 28886992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I have atrial fibrillation and cannot take beta-blockers. What are my alternatives?
    Johns Hopkins Med Lett Health After 50; 1999 Jul; 11(5):8. PubMed ID: 10377912
    [No Abstract]   [Full Text] [Related]  

  • 16. Pre-treatment with Irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation.
    Dagres N; Karatasakis G; Panou F; Athanassopoulos G; Maounis T; Tsougos E; Kourea K; Malakos I; Kremastinos DT; Cokkinos DV
    Eur Heart J; 2006 Sep; 27(17):2062-8. PubMed ID: 16891381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study.
    Manios EG; Mavrakis HE; Kanoupakis EM; Kallergis EM; Dermitzaki DN; Kambouraki DC; Vardas PE
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):31-9. PubMed ID: 12843685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of symptomatic atrial fibrillation.
    Haghi D; Schumacher B
    Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing A-fib: rhythm or rate? For many, rate control may be preferable to rhythm control.
    Carlson MD
    Health News; 2003 Feb; 9(2):3. PubMed ID: 12632539
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of amiodarone treatment on outcome after direct current cardioversion in atrial fibrillation: should we cardiovert atrial fibrillation of longer duration.
    Agarwal SC; Pepper CB
    Int J Cardiol; 2007 May; 117(3):406-7. PubMed ID: 16904207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.